Photo by https://kaboompics.com/ on Pexels
Kernikterus akibat Isoimunisasi (ICD-10: P57.0): Penyebab, Gejala, Diagnosis, dan Penanganan
📚 Daftar Pustaka (APA 7)
[1]
American Academy of Pediatrics. (2022). Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics, 150(3), e2022058572.
[2]
Dennery, P. A., Seidman, D. S., & Stevenson, D. K. (2021). Neonatal Hyperbilirubinemia. New England Journal of Medicine, 384(13), 1241-1252.
[3]
Kaplan, M., & Bromiker, R. (2020). Hemolytic Disease of the Newborn and Bilirubin Encephalopathy. Clinics in Perinatology, 47(2), 307-323.
[4]
Watchko, J. F., & Tiribelli, C. (2021). Bilirubin-Induced Neurologic Damage — Mechanisms and Management Approaches. New England Journal of Medicine, 385(17), 1607-1619.
[5]
World Health Organization. (2023). Guidelines on Neonatal Jaundice Management. Geneva: WHO Press.
[6]
Bhutani, V. K., & Wong, R. J. (2022). Bilirubin Neurotoxicity in Preterm Infants: Risk and Prevention. Journal of Perinatology, 42(1), 12-18.
[7]
Manning, D., et al. (2020). Prevention of Kernicterus: A Comparative Review of the Evidence. Journal of Perinatal Medicine, 48(6), 545-553.